|
|
|
| INTERPHEX is back in New York with exciting show features. This includes a BRAND-NEW Conference Program! The INTERPHEX Conference will unfold in the Learning Lab on the Exhibit Hall floor of INTERPHEX. It will feature peer-reviewed scientific presentations that examine quality systems, contamination control strategies for cell and gene therapies, 3D bioprinting, AI applications for formulations, and U.S. FDA regulatory updates, among other hot industry topics. Register today. |
|
|
|
|
By Irwin Hirsh, Q-Specialists AB | Poor knowledge management delays regulatory approval and, thus, market access. Here's the first in a series examining the complexity of knowledge management for CMC and across the value stream. |
|
|
|
|
|
|
| Quality Assurance And Your CDMO | Article | By Chantale G. Robles, Grifols | The result of regulatory compliance with quality standards is binary, but the processes employed to get there do not need to be rigid, inefficient, or expensive. Learn how innovation drives efficiencies. |
|
|
| AAV Purification Using AEX And Mixed-Mode Chromatography | Webinar | Bio-Rad Laboratories, Inc. | Recombinant adeno‐associated viruses (rAAV) are among the most promising vectors for long‐term gene transduction. In this study we explore chromatography workflow solutions to purify rAAV8. |
|
|
| Global Manufacturing Capabilities | Brochure | AGC Biologics | Combine deep industry expertise with innovative solutions and technologies, comprehensive service offerings, and a uniquely customized, client-centered approach. |
|
|
|
|
| Is It Ever Too Soon To Start Your Performance Testing Assessment? | Article | By Mike Ulman, West Pharmaceutical Services, Inc. | Developing a safe and effective injectable combination product involves performing risk assessments, establishing a set of critical quality attributes (CQAs), and performing design verification testing. |
|
|
|
| Current And Emerging Technologies To Optimize mRNA Manufacturing | Article | By Clemens Jakobi, Michał Domanski, and Telmo Graca, Lonza | Explore the benefits of using mRNA for vaccines and therapeutics, and learn how to address technical, intellectual property, and cost considerations when considering commercial production. |
|
|
| Optimizing Plasmid Production Strategies And Partnerships | Article | By Erika Morris, Ajinomoto Bio-Pharma Services | To find the plasmid manufacturer with the appropriate knowledge and experience to manufacture your plasmid with quality and efficiency, you’ll need to recognize the offerings of a seasoned supplier. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|